Brief: Aileron Therapeutics Inc - On February 16, 2023, Board Determined To Reduce Company's Remaining Workforce From Nine To Three Employees
24/02/2023 24:12
Feb 23 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS INC - ON FEBRUARY 16, 2023, BOARD
DETERMINED TO REDUCE COMPANY'S REMAINING WORKFORCE FROM NINE TO
THREE EMPLOYEES
Source text for Eikon: ID:
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering